A trio of antitrust complaints stretching back to 2016 have yielded a payoff, with generic drugmakers Heritage Pharmaceuticals and Apotex now on the hook to lay out a combined $49.1 million in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results